skip to main content

Chemistry, part 2

Content language

Contact us: CRM@email.irandoc.ac.ir

Concept information

... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > organonitrogen heterocyclic compound > imidazopyrimidine > purines > purine nucleoside > /{[3,4-dihydroxy-5-(6-hydroxy-2-imino-3,9-dihydro-2h-purin-9-yl)oxolan-2-yl]methoxy/}sulfonic acid
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > imidazopyrimidine > purines > purine nucleoside > /{[3,4-dihydroxy-5-(6-hydroxy-2-imino-3,9-dihydro-2h-purin-9-yl)oxolan-2-yl]methoxy/}sulfonic acid
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > imidazopyrimidine > purines > purine nucleoside > /{[3,4-dihydroxy-5-(6-hydroxy-2-imino-3,9-dihydro-2h-purin-9-yl)oxolan-2-yl]methoxy/}sulfonic acid
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > imidazopyrimidine > purines > purine nucleoside > /{[3,4-dihydroxy-5-(6-hydroxy-2-imino-3,9-dihydro-2h-purin-9-yl)oxolan-2-yl]methoxy/}sulfonic acid
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organic heteropolycyclic compound > organic heterobicyclic compound > imidazopyrimidine > purines > purine nucleoside > /{[3,4-dihydroxy-5-(6-hydroxy-2-imino-3,9-dihydro-2h-purin-9-yl)oxolan-2-yl]methoxy/}sulfonic acid
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteropolycyclic compound > organic heterobicyclic compound > imidazopyrimidine > purines > purine nucleoside > /{[3,4-dihydroxy-5-(6-hydroxy-2-imino-3,9-dihydro-2h-purin-9-yl)oxolan-2-yl]methoxy/}sulfonic acid
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteropolycyclic compound > organic heterobicyclic compound > imidazopyrimidine > purines > purine nucleoside > /{[3,4-dihydroxy-5-(6-hydroxy-2-imino-3,9-dihydro-2h-purin-9-yl)oxolan-2-yl]methoxy/}sulfonic acid
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic aromatic compound > heteroarene > imidazopyrimidine > purines > purine nucleoside > /{[3,4-dihydroxy-5-(6-hydroxy-2-imino-3,9-dihydro-2h-purin-9-yl)oxolan-2-yl]methoxy/}sulfonic acid
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic aromatic compound > heteroarene > imidazopyrimidine > purines > purine nucleoside > /{[3,4-dihydroxy-5-(6-hydroxy-2-imino-3,9-dihydro-2h-purin-9-yl)oxolan-2-yl]methoxy/}sulfonic acid
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic aromatic compound > heteroarene > imidazopyrimidine > purines > purine nucleoside > /{[3,4-dihydroxy-5-(6-hydroxy-2-imino-3,9-dihydro-2h-purin-9-yl)oxolan-2-yl]methoxy/}sulfonic acid
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > heteroarene > imidazopyrimidine > purines > purine nucleoside > /{[3,4-dihydroxy-5-(6-hydroxy-2-imino-3,9-dihydro-2h-purin-9-yl)oxolan-2-yl]methoxy/}sulfonic acid
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > heteroarene > imidazopyrimidine > purines > purine nucleoside > /{[3,4-dihydroxy-5-(6-hydroxy-2-imino-3,9-dihydro-2h-purin-9-yl)oxolan-2-yl]methoxy/}sulfonic acid
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > heteroarene > imidazopyrimidine > purines > purine nucleoside > /{[3,4-dihydroxy-5-(6-hydroxy-2-imino-3,9-dihydro-2h-purin-9-yl)oxolan-2-yl]methoxy/}sulfonic acid
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > n-glycosyl compound > nucleoside > purine nucleoside > /{[3,4-dihydroxy-5-(6-hydroxy-2-imino-3,9-dihydro-2h-purin-9-yl)oxolan-2-yl]methoxy/}sulfonic acid
... > organooxygen compound > carbohydrates and carbohydrate derivatives > carbohydrate derivative > n-glycosyl compound > nucleoside > purine nucleoside > /{[3,4-dihydroxy-5-(6-hydroxy-2-imino-3,9-dihydro-2h-purin-9-yl)oxolan-2-yl]methoxy/}sulfonic acid
... > organooxygen compound > carbohydrates and carbohydrate derivatives > carbohydrate derivative > glycosyl compound > n-glycosyl compound > nucleoside > purine nucleoside > /{[3,4-dihydroxy-5-(6-hydroxy-2-imino-3,9-dihydro-2h-purin-9-yl)oxolan-2-yl]methoxy/}sulfonic acid
... > organooxygen compound > oxacycle > oxolanes > nucleoside > purine nucleoside > /{[3,4-dihydroxy-5-(6-hydroxy-2-imino-3,9-dihydro-2h-purin-9-yl)oxolan-2-yl]methoxy/}sulfonic acid
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > oxacycle > oxolanes > nucleoside > purine nucleoside > /{[3,4-dihydroxy-5-(6-hydroxy-2-imino-3,9-dihydro-2h-purin-9-yl)oxolan-2-yl]methoxy/}sulfonic acid
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > oxacycle > oxolanes > nucleoside > purine nucleoside > /{[3,4-dihydroxy-5-(6-hydroxy-2-imino-3,9-dihydro-2h-purin-9-yl)oxolan-2-yl]methoxy/}sulfonic acid
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > oxacycle > oxolanes > nucleoside > purine nucleoside > /{[3,4-dihydroxy-5-(6-hydroxy-2-imino-3,9-dihydro-2h-purin-9-yl)oxolan-2-yl]methoxy/}sulfonic acid
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > oxolanes > nucleoside > purine nucleoside > /{[3,4-dihydroxy-5-(6-hydroxy-2-imino-3,9-dihydro-2h-purin-9-yl)oxolan-2-yl]methoxy/}sulfonic acid
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > oxolanes > nucleoside > purine nucleoside > /{[3,4-dihydroxy-5-(6-hydroxy-2-imino-3,9-dihydro-2h-purin-9-yl)oxolan-2-yl]methoxy/}sulfonic acid
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > oxolanes > nucleoside > purine nucleoside > /{[3,4-dihydroxy-5-(6-hydroxy-2-imino-3,9-dihydro-2h-purin-9-yl)oxolan-2-yl]methoxy/}sulfonic acid
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > nucleobase-containing molecular entity > nucleoside > purine nucleoside > /{[3,4-dihydroxy-5-(6-hydroxy-2-imino-3,9-dihydro-2h-purin-9-yl)oxolan-2-yl]methoxy/}sulfonic acid
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic aromatic compound > heteroarene > nucleobase-containing molecular entity > nucleoside > purine nucleoside > /{[3,4-dihydroxy-5-(6-hydroxy-2-imino-3,9-dihydro-2h-purin-9-yl)oxolan-2-yl]methoxy/}sulfonic acid
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic aromatic compound > heteroarene > nucleobase-containing molecular entity > nucleoside > purine nucleoside > /{[3,4-dihydroxy-5-(6-hydroxy-2-imino-3,9-dihydro-2h-purin-9-yl)oxolan-2-yl]methoxy/}sulfonic acid
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic aromatic compound > heteroarene > nucleobase-containing molecular entity > nucleoside > purine nucleoside > /{[3,4-dihydroxy-5-(6-hydroxy-2-imino-3,9-dihydro-2h-purin-9-yl)oxolan-2-yl]methoxy/}sulfonic acid
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > heteroarene > nucleobase-containing molecular entity > nucleoside > purine nucleoside > /{[3,4-dihydroxy-5-(6-hydroxy-2-imino-3,9-dihydro-2h-purin-9-yl)oxolan-2-yl]methoxy/}sulfonic acid
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > heteroarene > nucleobase-containing molecular entity > nucleoside > purine nucleoside > /{[3,4-dihydroxy-5-(6-hydroxy-2-imino-3,9-dihydro-2h-purin-9-yl)oxolan-2-yl]methoxy/}sulfonic acid
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > heteroarene > nucleobase-containing molecular entity > nucleoside > purine nucleoside > /{[3,4-dihydroxy-5-(6-hydroxy-2-imino-3,9-dihydro-2h-purin-9-yl)oxolan-2-yl]methoxy/}sulfonic acid

Preferred term

/{[3,4-dihydroxy-5-(6-hydroxy-2-imino-3,9-dihydro-2h-purin-9-yl)oxolan-2-yl]methoxy/}sulfonic acid  

Type

  • http://www.irandoc.ac.ir/onto/irandoc-meta/Concept

Broader concept

charge

  • 0

formula

  • C10H13N5O8S

inchi

  • InChI=1S/C10H13N5O8S/c11-10-13-7-4(8(18)14-10)12-2-15(7)9-6(17)5(16)3(23-9)1-22-24(19,20)21/h2-3,5-6,9,16-17H,1H2,(H,19,20,21)(H3,11,13,14,18)

inchikey

  • NAAAVEJZEVEAMU-UHFFFAOYSA-N

mass

  • 363.300

monoisotopicmass

  • 363.04848

smiles

  • S(OCC1OC(N2C=3NC(=NC(=O)C3N=C2)N)C(O)C1O)(O)(=O)=O

subset

  • 2_STAR

synonym EXACT

  • [5-(2-amino-6-oxo-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl hydrogen sulate

In other languages

URI

http://www.irandoc.acir/onto/irandoc/CHEBI:185033

Download this concept:

RDF/XML TURTLE JSON-LD